X

Trial Profile

Utilization of Ticagrelor in the Upstream Setting for Non-ST-Segment Elevation Myocardial Infarction (UPSTREAM): An ED-Based Clinical Registry

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 05 Nov 2021

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Ticagrelor (Primary) ; Clopidogrel; Prasugrel
Indications Acute coronary syndromes; Cardiovascular disorders; Myocardial infarction; Stroke
Focus Adverse reactions; Therapeutic Use
Acronyms UPSTREAM
Sponsors AstraZeneca

Most Recent Events

11 Feb 2020 Status changed from active, no longer recruiting to completed.
04 Oct 2019 Status changed from recruiting to active, no longer recruiting.
14 Nov 2018 Results assessing the in-hospital outcomes of the first 2512 NSTEMI patients, presented at the 91st Annual Scientific Sessions of the American Heart Association

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com